These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4471743)

  • 21. [Atherosclerosis and lipid peroxide--evaluation of lipid peroxides as clinical paramater (author's transl)].
    Hata Y; Aihara K; Miyazaki K
    Nihon Ronen Igakkai Zasshi; 1978 May; 15(3):192-200. PubMed ID: 671819
    [No Abstract]   [Full Text] [Related]  

  • 22. Platelet survival time: its measurement and use.
    Harker LA
    Prog Hemost Thromb; 1978; 4():321-47. PubMed ID: 715221
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inhibitory mechanism of platelet energy production and platelet functions by PGE1 and uremic toxins (author's transl)].
    Kuramoto A
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):477-87. PubMed ID: 4799441
    [No Abstract]   [Full Text] [Related]  

  • 24. [Function of platelets in patients with occlusive atherosclerotic arterial disease of the lower extremities].
    Psuja P; Zozulińska M; Lewandowski K; Turowiecka Z; Pioruńska-Stolzmann M; Majewski W; Patelski J; Zawilska K
    Pol Arch Med Wewn; 1994 May; 91(5):349-55. PubMed ID: 8084811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipid metabolism of the platelet and platelet function (author's transl)].
    Okuma M
    Nihon Ketsueki Gakkai Zasshi; 1976 Oct; 39(5):682-93. PubMed ID: 1037350
    [No Abstract]   [Full Text] [Related]  

  • 26. Platelet derived growth factor (PDGF) and prostaglandins (PGE1, PGI2) as modulators of the atherogenetic process.
    Sinzinger H; Zidek T; Fitscha P; Kaliman J; Steurer G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):439-42. PubMed ID: 2465948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Membrane transport systems in human platelets.
    Yardimci TU
    Haematologica; 1980 Aug; 65(4):498-508. PubMed ID: 6774923
    [No Abstract]   [Full Text] [Related]  

  • 28. [How do plasma lipid changes in atherosclerosis act upon platelet physiology?].
    Bereziat G
    Sem Hop; 1979 Apr 18-25; 55(15-16):753-4. PubMed ID: 227064
    [No Abstract]   [Full Text] [Related]  

  • 29. [Platelets in biology and pathology during foetal and neonatal period (author's transl)].
    Shirahata A; Nojiri K
    Rinsho Ketsueki; 1982 Jan; 23(1):1-12. PubMed ID: 7047798
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies on the correlation between lipoperoxide and aging, with special reference to the vascular changes (author's transl)].
    Yoshimine N; Sato Y; Kuzuya F
    Nihon Ronen Igakkai Zasshi; 1978 May; 15(3):201-4. PubMed ID: 671820
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathological significances of the effects of lipid abnormality on the erythrocyte metabolism and its morphology, with special references to the etiology of senile anemia (author's transl)].
    Katsunuma H; Takasaki M; Ebihara T; Tanabe T; Furukawa G
    Rinsho Ketsueki; 1974 Aug; 15(8):951-61. PubMed ID: 4475157
    [No Abstract]   [Full Text] [Related]  

  • 32. [The electrophoretic mobility of platelets. Short review of the literature and contribution with personal experience (author's transl)].
    Aznar J; Martínez-Sausor V; Valles J; Villa P
    Sangre (Barc); 1978; 23(1):13-30. PubMed ID: 635728
    [No Abstract]   [Full Text] [Related]  

  • 33. The influence of long-term therapy with phenformin plus metanabol on blood fibrinolytic activity, platelet adhesiveness and lipid metabolism in patients with arteriosclerosis.
    Perzanowski A; Bielawiec M; Myśliwiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(3):381-8. PubMed ID: 63425
    [No Abstract]   [Full Text] [Related]  

  • 34. [lipid metabolism and ageing (author's transl)].
    Richter V; Rotzsch W
    Z Alternsforsch; 1980; 34(6):489-96. PubMed ID: 7210710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of peripheral arterial disease on circulating platelets.
    McBane RD; Karnicki K; Miller RS; Owen WG
    Thromb Res; 2004; 113(2):137-45. PubMed ID: 15115669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum lipid profiles in xanthoma patients--correlative study on xanthoma and atherosclerosis (author's transl)].
    Hata Y; Shigematsu H
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1242-7. PubMed ID: 7462753
    [No Abstract]   [Full Text] [Related]  

  • 37. [Platelet function in experimental hemorrhagic shock (author's transl)].
    Yamada H; Yoshimura N
    Masui; 1980 Feb; 29(2):123-8. PubMed ID: 7365995
    [No Abstract]   [Full Text] [Related]  

  • 38. [Significance of blood platelets and coagulation for development, progression and regression of arteriosclerosis].
    Hess H
    Vasa Suppl; 1987; 20():56-61. PubMed ID: 3321496
    [No Abstract]   [Full Text] [Related]  

  • 39. Biochemistry and physiology of blood platelets.
    Holmsen H; Day HJ
    Ann Clin Lab Sci (1971); 1971; 1(1):38-47. PubMed ID: 5161281
    [No Abstract]   [Full Text] [Related]  

  • 40. [Symposium on the blood coagulation and fibrinolysis. (5) Metabolic and kinetic studies of platelets in thromogenesis (author's transl)].
    Kuramoto A
    Nihon Naika Gakkai Zasshi; 1975 Oct; 64(10):1115-20. PubMed ID: 1238478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.